PRKCD and neoplasm: To dissect the dynamic changes of both kinases and phosphoproteins in PDAC, we performed kinase–substrate enrichment analysis (KSEA) (Methods), and four kinases (HIPK2, ROCK1, PRKCD, MAPKAPK2) were identified as tumor-specific activated.